XML 88 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Geneos Therapeutics, Inc. - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 7 Months Ended 12 Months Ended
Jun. 01, 2020
Nov. 30, 2020
Feb. 28, 2019
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2021
Feb. 28, 2021
Jun. 30, 2020
Mar. 31, 2020
Jan. 01, 2020
Noncontrolling Interest [Line Items]                          
Payments to acquire additional interest in subsidiaries           $ 0 $ 1,399,999 $ 0          
Gain on deconsolidation of Geneos           0 4,121,075 0          
Share in net loss of Geneos           434,387 4,584,610 $ 0          
Investment in Geneos         $ 434,387 $ 0 $ 434,387            
Series A-1 Preferred Stock                          
Noncontrolling Interest [Line Items]                          
Investment in Geneos $ 1,399,999                        
Geneos Therapeutics, Inc.                          
Noncontrolling Interest [Line Items]                          
Noncontrolling interest, ownership percentage by parent   36.00% 61.00%             35.00% 47.00% 52.00%  
Percentage of ownership           47.00%              
Geneos Therapeutics, Inc.                          
Noncontrolling Interest [Line Items]                          
Payments to acquire additional interest in subsidiaries   $ 1,400,000 $ 1,200,000                    
Stock purchase agreement, commitment of additional investment                 $ 800,000       $ 800,000
Gain on deconsolidation of Geneos 4,121,075                        
Deconsolidation gain, remeasurement of retained noncontrolling investment to fair value 2,400,000                        
Loss from equity method investment, recorded and allocated to investment       $ 1,500,000 4,600,000                
Share in net loss of Geneos       434,387 4,584,610                
Investment in Geneos 3,618,998     0   $ 0     $ 0        
Geneos Therapeutics, Inc. | Common stock                          
Noncontrolling Interest [Line Items]                          
Share in net loss of Geneos         819,000                
Investment in Geneos $ 819,000     $ 0                  
Geneos Therapeutics, Inc. | Series A-1 Preferred Stock                          
Noncontrolling Interest [Line Items]                          
Share in net loss of Geneos         $ 4,200,000                
Investment in Geneos           $ 0